Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Anjali Kusumbe has been awarded an MRC Career Development Award to support her research examining how blood vessels support bone growth and repair.

The prestigious five-year MRC Career Development Award is designed to support talented early stage scientists as they transition to become independent investigators. The award will allow Anjali to pursue an ambitious programme of research aimed at understanding how blood vessels might be targeted to stimulate new bone growth in disease.

Bone is maintained through a delicate balance between breakdown of existing tissue and formation of new bone by cells called osteoblasts. During aging, however, new bone formation becomes less efficient, increasing risk of fractures and other musculoskeletal disorders.

Anjali's previous research as a postdoctoral fellow at the Max Plank Institute, Germany identified a certain type of endothelial cells in blood vessels that create a nurturing environment for bone progenitors. Experimental activation of these endothelial cells could increase bone mass during aging.

Anjali now wants to better understand the signals and cell types that mediate communication between blood vessels and stem/progenitor cells. She hopes this will lead to new strategies to manipulate bone growth and turnover.

Speaking of her award, Anjali said: "It is crucial to improve our understanding of the bone marrow microenvironment in order to identify startegies to treat bone diseases. I'm really excited. Getting an MRC Career Development Award acknowledges the fact that the project is good enough to be financed externally".

Anjali joined the Kennedy Institute in July 2016 supported by funds from the Kennedy Trust for Rheumatology Research.

Similar stories

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Reflecting on the role of Clinical Director of Trauma and Orthopaedics

In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.